Vancomycin injection recalled due to sterility assurance concerns
Central Admixture Pharmacy Services is recalling vancomycin injections (1 g/250 mL) nationwide due to concerns about sterility assurance identified during FDA inspection. The recall affects 4,390 bags.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: This is a FDA Class II recall with no reported hospitalizations, illnesses, or injuries. The hazard—lack of sterility assurance for an injectable medication—poses a theoretical risk of harm, placing it in the High severity category per the rubric.
Plain-English summary
Central Admixture Pharmacy Services, Inc. is recalling vancomycin injections (1 g/250 mL, 4 mg/mL) distributed nationwide. The recall affects 4,390 bags across multiple lot numbers.
The FDA inspection questioned the sterility assurance of these products. Vancomycin is a prescription injectable medication that must be sterile to be safe for use.
The affected lots were distributed nationwide. Consumers and healthcare providers who have received products with the following lot numbers should stop using them: Lot #37-885351 (Exp 05/08/2023), 37-885979 (Exp 05/10/2023), 37-887721 (Exp 05/17/2023), 37-889212 (Exp 05/23/2023), 37-889607 (Exp 05/24/2023), 37-891247 (Exp 05/31/2023), 37-892937 (Exp 06/07/2023), 37-894025 (Exp 06/12/2023), 37-894748 (Exp 06/14/2023), 37-895282 (Exp 06/18/2023), 37-896173 (Exp 06/20/2023).
If you or your healthcare provider have used this medication, speak with a healthcare provider. Do not use any remaining product with the recalled lot numbers. Contact Central Admixture Pharmacy Services or the FDA with questions.
The recalled product
- Product
- vancomycin added to 0.9% sodium chloride, 1 g/250 mL* (4 mg/mL), 25 250 mL per bag, Rx only, Central Admixture Pharmacy Services, Inc., 6580 Snowdrift Rd., Ste 100, Allentown, PA 18106, NDC 71285-6064-1.
- Manufacturer
- Central Admixture Pharmacy Services, Inc.
- Category
- Drug — Injectable / Antibiotic
- Hazard
- sterile-assurance
- contamination
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (20)
- Lot # 37-885351
- Exp 05/08/2023
- 37-885979
- Exp 05/10/2023
- 37-887721
- Exp 05/17/2023
- 37-889212
- Exp 05/23/2023
- 37-889607
- Exp 05/24/2023
- 37-891247
- Exp 05/31/2023
- 37-892937
- Exp 06/07/2023
- 37-894025
- Exp 06/12/2023
- 37-894748
- Exp 06/14/2023
- 37-895282
- Exp 06/18/2023
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27